BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19836800)

  • 1. Clinicopathological behavior of single focus prostate adenocarcinoma.
    Rice KR; Furusato B; Chen Y; McLeod DG; Sesterhenn IA; Brassell SA
    J Urol; 2009 Dec; 182(6):2689-94. PubMed ID: 19836800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.
    Arora R; Koch MO; Eble JN; Ulbright TM; Li L; Cheng L
    Cancer; 2004 Jun; 100(11):2362-6. PubMed ID: 15160339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laterality alone should not drive selection of candidates for hemi-ablative focal therapy.
    Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS
    J Urol; 2009 Mar; 181(3):1082-9; discussion 1089-90. PubMed ID: 19150090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series.
    Han M; Partin AW; Chan DY; Walsh PC
    J Urol; 2004 Jan; 171(1):23-6. PubMed ID: 14665835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy.
    Miyamoto H; Hernandez DJ; Epstein JI
    Hum Pathol; 2009 Dec; 40(12):1693-8. PubMed ID: 19683331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of multiple biopsy cores on predicting final tumor volume in prostate cancer detected by a single microscopic focus of cancer on biopsy.
    Guzzo TJ; Vira M; Hwang WT; D'amico A; Tomaszewski J; Whittington R; Wein AJ; Vanarsdalen K; Malkowicz SB
    Urology; 2005 Aug; 66(2):361-5. PubMed ID: 16098364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy.
    Kordan Y; Chang SS; Salem S; Cookson MS; Clark PE; Davis R; Herrell SD; Baumgartner R; Phillips S; Smith JA; Barocas DA
    J Urol; 2009 Nov; 182(5):2291-5. PubMed ID: 19758638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
    Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
    J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
    J Urol; 2009 Nov; 182(5):2250-5. PubMed ID: 19758614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease.
    Helfand BT; Mongiu AK; Kan D; Kim DY; Loeb S; Roehl KA; Meeks JJ; Smith ND; Catalona WJ
    BJU Int; 2009 Aug; 104(3):304-9. PubMed ID: 19239451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure.
    Adam C; Salomon G; Walther S; Zaak D; Khoder W; Becker A; Reich O; Blana A; Ganzer R; Denzinger S; Popken G; Sroka R; Knüchel-Clarke R; Köllermann J; Sauter G; Hartmann A; Bertz S; Graefen M; Huland H; Wieland W; Stief CG
    Eur Urol; 2009 Jun; 55(6):1281-8. PubMed ID: 19328622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of surgical margins between radical retropubic prostatectomy and RALP: are patients sacrificed during initiation of robotics program?
    White MA; De Haan AP; Stephens DD; Maatman TK; Maatman TJ
    Urology; 2009 Mar; 73(3):567-71. PubMed ID: 19167036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database.
    Freedland SJ; Bañez LL; Sun LL; Fitzsimons NJ; Moul JW
    Prostate Cancer Prostatic Dis; 2009; 12(3):259-63. PubMed ID: 19581922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma.
    Merrimen JL; Jones G; Walker D; Leung CS; Kapusta LR; Srigley JR
    J Urol; 2009 Aug; 182(2):485-90; discussion 490. PubMed ID: 19524976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes in younger men following permanent prostate brachytherapy.
    Shapiro EY; Rais-Bahrami S; Morgenstern C; Napolitano B; Richstone L; Potters L
    J Urol; 2009 Apr; 181(4):1665-71; discussion 1671. PubMed ID: 19233394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between upgrading of prostate biopsy and biochemical failure and unfavorable pathology after radical prostatectomy.
    Ozden C; Oztekin CV; Ugurlu O; Gokkaya S; Yaris M; Memis A
    Urol Int; 2009; 83(2):146-50. PubMed ID: 19752607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy.
    Shepard DR; Dreicer R; Garcia J; Elson P; Magi-Galluzzi C; Raghavan D; Stephenson AJ; Klein EA
    J Urol; 2009 Apr; 181(4):1672-7; discussion 1677. PubMed ID: 19230915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
    Capitanio U; Ahyai S; Graefen M; Jeldres C; Shariat SF; Erbersdobler A; Schlomm T; Haese A; Steuber T; Heinzer H; Perrotte P; Péloquin F; Pharand D; Arjane P; Huland H; Karakiewicz PI
    Urology; 2008 Dec; 72(6):1208-11; discussion 1212-3. PubMed ID: 18692880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy.
    Ward JF; Nakanishi H; Pisters L; Babaian RJ; Troncoso P
    BJU Int; 2009 Aug; 104(4):490-7. PubMed ID: 19220260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma.
    Aizer AA; Yu JB; McKeon AM; Decker RH; Colberg JW; Peschel RE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1344-9. PubMed ID: 19464821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.